We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Eden Research Plc | LSE:EDEN | London | Ordinary Share | GB0001646941 | ORD 1P |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 4.25 | 4.00 | 4.50 | 4.25 | 4.25 | 4.25 | 255,065 | 08:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Biological Pds,ex Diagnstics | 1.83M | -2.24M | -0.0042 | -10.12 | 22.67M |
From Apr 2022 to Apr 2024
By Jaime Llinares Taboada
Eden Research PLC said Tuesday that it has passed a key milestone for the approval of its products in the U.S.
The London-listed sustainable biopesticides company said that the U.S. Environmental Protection Agency has granted its Sustaine technology an exemption from the requirement of a tolerance for residues in pesticide formulations in pre-harvest applications to crops. Eden expects its three active ingredients and two formulated products to receive U.S. authorization this year.
In addition, the company said that its Mevalone biofungicide has received authorization for use on new crops in Italy for the control of botrytis cinerea disease.
Write to Jaime Llinares Taboada at jaime.llinares@wsj.com; @JaimeLlinaresT
(END) Dow Jones Newswires
May 10, 2022 03:03 ET (07:03 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.
1 Year Eden Research Chart |
1 Month Eden Research Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
